Blindness secondary to prostate cancer
- PMID: 8149144
- DOI: 10.1007/BF00366063
Blindness secondary to prostate cancer
Abstract
We report a case of blindness, secondary to hormone-refractory prostate cancer, occurring 7 years after the diagnosis of metastatic prostate cancer and 3.5 years after the clinical onset of the hormone-refractory state. Prolonged suppression of the disease with chemotherapy may have contributed to the unusual clinical findings. We discuss the role of supportive care in the management of prostate cancer.
References
Publication types
MeSH terms
LinkOut - more resources
Medical